Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Volume 2 Supplement 2

Abstracts of the 1st Immunotherapy of Cancer Conference (ITOC1)

Meeting abstracts

Edited by Heinz Zwierzina and Volkmar Nuesslar

Publication of this supplement was funded by the Biotherapy Development Association, a non-profit organisation. The Supplement Editors declare that they have no competing interests.

1st Immunotherapy of Cancer Conference (ITOC1). Go to conference site.

Munich, Germany12-14 March 2014

Page 1 of 2

  1. Authors: H Schmoll, BW Wittig, DA Arnold, JRK Riera-Knorrenschild, DN Nietsche, HK Kroening, FM Mayer, JA Andel, RZ Ziebermayr and WS Scheithauer

    Citation: Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I2

    Content type: Invited speaker presentation

    Published on: